Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05065502 · ClinicalTrials.gov registry record · NA

MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT05065502: Completed NA study, sponsored by VA Office of Research and Development.

NCT05065502 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05065502, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

Scientific advances are constantly leading to better treatments. However, it is quite challenging for healthcare systems, including VA, to ask very busy providers to change the way they practice. The MIDAS QUERI program will help providers improve the way they treat VA patients for three common conditions, using specific strategies to ensure the reliable delivery of these treatments. The first project will focus on reducing potentially inappropriate medication (PIM) use using the VIONE practice, developed in VA. The second project will focus on better use of drugs called direct oral anticoagulants (DOACs) for patients with a history of severe blood clots or an abnormal heart rhythm. The third project will focus on increasing the use of cognitive behavioral therapy for insomnia as the first-line treatment for insomnia instead of sleep medications. The investigators will test two implementation approaches to improve medication use within these topics.

Interventions

  • BEHAVIORAL Academic Detailing (AD)
  • BEHAVIORAL LEAP

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-05-03
Est. Completion 2024-05-14
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT05065502

The ClinicalTrials.gov registry entry for NCT05065502 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Academic Detailing (AD) is the first listed.

NCT05065502 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05065502 about?

NCT05065502 is a clinical study titled "MIDAS Cluster Randomized Controlled Trial of Implementation Strategies to Optimize Use of Medications in VA Clinical Settings". Scientific advances are constantly leading to better treatments. However, it is quite challenging for healthcare systems, including VA, to ask very busy providers to change the way they practice. The MIDAS QUERI program will help providers improve the way they treat VA patients for three common cond...

What is the current status of trial NCT05065502?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-05-03. Estimated completion is 2024-05-14.

What interventions are being tested in trial NCT05065502?

The interventions under investigation include: Academic Detailing (AD) (BEHAVIORAL), LEAP (BEHAVIORAL).

Who is sponsoring clinical trial NCT05065502?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.